Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Am J Hematol. 2013 Feb 6;88(4):245–250. doi: 10.1002/ajh.23385

Table III.

Associations of Burkitt lymphoma incidence with recipient clinical characteristics

Characteristic BL cases Incidence rates* Incidence rate ratios 95% confidence intervals
Transplanted organ
 Heart 20 18.1 2.98 1.68, 5.16
 Kidney 32 6.1 Ref.
 Liver 43 21.3 3.51 2.23, 5.59
 Lung 1 3.6 0.60 0.03, 2.77
 Other 3 6.3 1.03 0.25, 2.88
EBV serostatus
 Negative 8 22.5 Ref.
 Positive 9 5.4 0.24 0.09, 0.64
 Unknown/missing 82 11.5 0.51 0.26, 1.15
CMV serostatus
 Negative 14 13.1 Ref.
 Positive 10 5.2 0.40 0.17, 0.88
 Unknown/missing 75 12.2 0.93 0.54, 1.72
HIV serostatus
 Negative 33 13.4 Ref.
 Positive 1 288 21.5 1.21, 99.7
 Unknown/missing 65 9.7 0.73 0.48, 1.12
Medical conditions
Diabetes mellitus
 No 57 13.9 Ref.
 Yes 11 8.9 0.64 0.32, 1.18
 Missing 31 8.2 0.59 0.38, 0.91
Non-cholestatic cirrhosis
 No 24 32.9 Ref.
 Yes 19 14.8 0.45 0.24, 0.82
Cholestatic liver disease/cirrhosis
 No 31 18.1 Ref.
 Yes 12 39.4 2.18 1.07, 4.12
*

Incidence is per 100,000 person-years;

results from tests conducted at baseline;

Analysis is restricted to liver recipients